Enovis™ to Showcase New Surgical Innovations at AAHKS Annual Meeting
30 Octobre 2023 - 1:00PM
Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven,
medical technology company, announced it will showcase the latest
technologies from its Surgical business, including an updated
ARVIS® Augmented Reality System, EMPOWR™ blade stem, and EMPOWR 3D
Knee® at the American Association of Hip and Knee Surgeons annual
meeting in Grapevine, Texas, November 2-5, 2023.
“Enovis is dedicated to surgeon-centric innovation that creates
value for all stakeholders and ultimately improves patient
outcomes,” stated Louie Vogt, President and General Manager of
Enovis™ Surgical. “Cost effective and scalable enabling
technologies have a bright future and we’re excited to take our
ARVIS Augmented Reality System to the next level with new features
that enable surgeons to quickly plan, execute and verify precise
implant alignment, as well as now offering implant rotation and
tissue balancing capabilities. We’re also thrilled to be
launching our EMPOWR blade stem, which is designed to fit better
than traditional blade stems and offers intraoperative efficiency
through expanded options and streamlined instrumentation.”
Other offerings being showcased will include EMPOWR 3D Knee®
which is the first and only dual pivot total knee on the market
replicating natural motion.2,3 Additionally, Enovis will be hosting
a symposium discussing our efficient revision offerings, EMPOWR
Revision Knee and EXPRT Hip System.
AAHKS attendees can experience these products firsthand at booth
#501.
References:
- Competitive data retrieved from competitors’ websites
- Meneghini, R. M., Deckard, E. R., Ishmael, M. K., &
Ziemba-Davis, M. (2017). A dual-pivot pattern simulating native
knee kinematics optimizes functional outcomes after total knee
arthroplasty. The Journal of Arthroplasty, 32(10), 3009–3015.
https://doi.org/10.1016/j.arth.2017.04.050
- Sandberg, Rory, et al. "Dual-pivot bearings improve ambulation
and promote increased activity levels in Total knee arthroplasty: A
match-controlled retrospective study." The Knee 26.6 (2019):
1243-1249.
About EnovisEnovis Corporation (NYSE: ENOV) is
an innovation-driven, medical technology growth company dedicated
to developing clinically differentiated solutions that generate
measurably better patient outcomes and transform workflows. Powered
by a culture of continuous improvement, global talent and
innovation, the Company’s extensive range of products, services,
and integrated technologies fuels active lifestyles in orthopedics
and beyond. For more information about Enovis, please visit
www.enovis.com.
Media Contact:Kristen VickEnovis (512)
810-7899Kristen.Vick@enovis.com
- SU-2206-ARVIS2.0-PRD-HEADSET3_4 LEFT_ON BODY
- EMPOWR_Porous_Patella_Image_01 (3)
- BladeStem_LinearStandard_Side
Enovis (NYSE:ENOV)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Enovis (NYSE:ENOV)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024